A prospective, multi-center, observational study on the use of interferon beta-1a (Rebif) therapy in Egyptian patients with Multiple Sclerosis
نویسندگان
چکیده
منابع مشابه
A prospective, multi-center, observational study on the use of interferon beta-1a (Rebif) therapy in Egyptian patients with Multiple Sclerosis
Objective: The primary objective of this study is to describe the disease characteristics of the cohort of MS patients undergoing Rebif treatment. Design: This is a multicentre, open label, non comparative, non randomized study conducted in Egypt on the use of interferon beta-1a (Rebif) therapy in Egyptian patients with relapsing multiple sclerosis according to McDonald criteria. Subjects: Egyp...
متن کاملInterferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study
The efficacy and safety of first-line disease-modifying therapies (DMT) for relapsing-remitting multiple sclerosis (RRMS) has been demonstrated in pivotal, randomized trials, but these studies do not reflect the routine care setting where treatment gaps or switches are common. The Avonex as Treatment Option for Untreated MS Patients (AXIOM) trial assessed the efficacy of newly-initiated intramu...
متن کاملFingolimod versus High Dose Interferon Beta-1a in Multiple Sclerosis: A Randomized Clinical Trial
Background: High dose Interferon Beta and Fingolimod are efficient in Multiple Sclerosis. Objectives: Comparison the efficacy of these two drugs in patients with treatment failure on low dose interferon beta. Materials and Methods: The MS patients (McDonald criteria 2010) with the history of unbeneficial treatment on low dose interferon beta participated in this randomized clinical trial ...
متن کاملAntibodies to Interferon beta in Patients with Multiple Sclerosis Receiving CinnoVex, Rebif, and Betaferon
Treatment with interferon beta (IFN-β) induces the production of binding antibodies (BAbs) and neutralizing antibodies (NAbs) in patients with multiple sclerosis (MS). NAbs against IFN-β are associated with a loss of IFN-β bioactivity and decreased clinical efficacy of the drug. The objective of this study was to evaluate the incidence and the prevalence of binding antibodies (BAbs) and neutral...
متن کاملInhibitory effect of the interferon-beta on the release of endothelial cell derived microparticles in patients with multiple sclerosis
Abstract Introduction: Increased levels of microparticles (MPs) have been reported in many autoimmune diseases such as multiple sclerosis (MS). In MS, endothelial cells release MPs from their membranes following the activation of lymphocytes and the production of inflammatory cytokines. The aim of this study was to investigate the inhibitory effect of interferon beta (INFβ) on the release of en...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Egyptian Journal of Hospital Medicine
سال: 2013
ISSN: 2090-7125
DOI: 10.21608/ejhm.2013.16073